ECSP003351A - PHARMACEUTICAL COMPOSITIONS - Google Patents

PHARMACEUTICAL COMPOSITIONS

Info

Publication number
ECSP003351A
ECSP003351A ECSP003351A ECSP003351A EC SP003351 A ECSP003351 A EC SP003351A EC SP003351 A ECSP003351 A EC SP003351A EC SP003351 A ECSP003351 A EC SP003351A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical compositions
bioavailability
benzoyl staurosporine
levels
compositions
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Graham Paul Matthews
Barbara Haberlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003351 priority Critical patent/ECSP003351A/en
Publication of ECSP003351A publication Critical patent/ECSP003351A/en

Links

Abstract

Se describen composiciones de N-benzoil-estaurosporina espontáneamente desipersables para la administarción oral, que tienen alqtos niveles de biodisponibilidad, y una variedad reducida de lso niveles de biodisponibilidad de N-benzoil estaturosporina, asi como su preparación y su uso en tratamiento médico.Spontaneously dispersible N-benzoyl staurosporine compositions for oral administration are described, which have high levels of bioavailability, and a reduced range of bioavailability levels of N-benzoyl staurosporine, as well as their preparation and use in medical treatment.

ECSP003351 2000-02-15 2000-02-15 PHARMACEUTICAL COMPOSITIONS ECSP003351A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003351 ECSP003351A (en) 2000-02-15 2000-02-15 PHARMACEUTICAL COMPOSITIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003351 ECSP003351A (en) 2000-02-15 2000-02-15 PHARMACEUTICAL COMPOSITIONS

Publications (1)

Publication Number Publication Date
ECSP003351A true ECSP003351A (en) 2000-05-08

Family

ID=42040982

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003351 ECSP003351A (en) 2000-02-15 2000-02-15 PHARMACEUTICAL COMPOSITIONS

Country Status (1)

Country Link
EC (1) ECSP003351A (en)

Similar Documents

Publication Publication Date Title
ECSP083351A (en) PHARMACEUTICAL COMPOSITIONS
CY1105262T1 (en) EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR THE PARENTANEOUS ADMINISTRATION OF BIOLOGICALLY ACTIVE HYDROPHILIC COMPOUNDS
WO2004112711A3 (en) Oral extended-release composition
EE05081B1 (en) Pharmaceutical compositions containing 3-aminoacetidine derivatives, 3-aminoacetidine derivatives and methods for their preparation
BG66093B1 (en) Controlled release compositions comprising nimesulide
EE05383B1 (en) Pol arecarboxamide Compounds, Preparation and Use of Aliphatic Lowering Active Ingredients and Pharmaceutical Ingredients
ATE302616T1 (en) MEDICINAL COMPOSITIONS FOR ORAL APPLICATION WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
NO20062504L (en) Compositions and dosage forms for improved absorption
DE60038183D1 (en) COMPOUNDS AND COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS
CY1110906T1 (en) PHARMACEUTICAL COMPOSITION FOR NON-ADMINISTRATION OF FENTANYL
AU2003215245A8 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AR034517A1 (en) PHARMACEUTICAL FORMULATION
UA86776C2 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TNSN05222A1 (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino) phenylacetic acid
IS7006A (en) Dihydrogen 3-piperidinopropiophenone and medicinal products containing said compounds
WO2002011694A3 (en) Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
ATE398109T1 (en) 4-PYRIMIDINAMININE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS
DE60202590D1 (en) 2H-1-BENZOPYRANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
BR0111055A (en) Pharmaceutical formulation and process for the preparation and use thereof
TR200301553A1 (en) New oral pharmaceutical formulations containing irbesartan active ingredient
ECSP003351A (en) PHARMACEUTICAL COMPOSITIONS
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
EA200601015A1 (en) ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION
DE60126046D1 (en) Bicyclic amino-pyrazone derivatives, their preparation and pharmaceutical compositions
EE05401B1 (en) Imidazolidine derivatives, their preparation and their use as anti-inflammatory agents and pharmaceutical preparations containing them